Flag of the European Union EU Clinical Trials Register Help

Clinical trials for NTU

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  3  Next»
    Study title: Short-time-immunotherapy with Allergoids, results from prospective, open Study in allergergological practices; Allergovit patients with seasonal rhino conjunctivitis and/or asthma symptoms Age of patients: 4 – 75 Years, 2047 Patients Allergologie, Jahrgang 28, Nr. 10/2005, S. 391-400
    Active substance: 006 Grasses (178 Kentucky Blue Grass, 179 Meadow Fescue, 140 Orchard Grass, 157 Rye Grass, 177 Timothy Grass, 133 Velvet Grass)
    Study summary document link (including results):
    View full study record
    Document reference: 39754
    Study title: Intubation without muscle relaxation - Alfentanil/ Propofol as an alternative inducation regime for children. Anesthesiology 89 (n°3 A) A,1316,1998 Intubation without muscle relaxation - Alfentanil/ Propofol as an alternative inducation regime for children. Anesthesiology 89 (n°3 A) A,1316,1998
    Active substance: ALFENTANIL
    Study summary document link (including results): erlacher_alfentanil.pdf
    View full study record
    Document reference: 46367
    Study title: LMD124245 - Belzarena SD. Nasal intubation in paediatric patients. Comparison between a combination of alfentanil and lidocaine versus succinylcholine [translation]. Revista Brasileira de Anestesiologia, 46 (5), p. 323-328, 1996.LMD124245 - Belzarena SD. Nasal intubation in paediatric patients. Comparison between a combination of alfentanil and lidocaine versus succinylcholine [translation]. Revista Brasileira de Anestesiologia, 46 (5), p. 323-328, 1996.
    Active substance: ALFENTANIL
    Study summary document link (including results): belzarenaengabstract_alfentanil.pdf
    View full study record
    Document reference: 46369
    Study title: LMD126087 - Senel AC, Aktürk G, Yurtseven M. Comparison of intubation conditions under propofol in children. Middle East Journal of Anesthesiology, 13 (A), p. 605-611, 1996.LMD126087 - Senel AC, Aktürk G, Yurtseven M. Comparison of intubation conditions under propofol in children. Middle East Journal of Anesthesiology, 13 (A), p. 605-611, 1996.
    Active substance: ALFENTANIL
    Study summary document link (including results): seneldumanenglishabstract_alfentanil.pdf
    View full study record
    Document reference: 46366
    Study title: LMD134297 - Erlacher W, Kontraratos M, Müller C, Gradwohl I, Grubhofer G, Semsroth M. Intubation without muscle relaxation - alfentanil/propofol as an alternative induction regime for children. Anaesthesiology, 89 (3A), abstract A1316 1998.LMD134297 - Erlacher W, Kontraratos M, Müller C, Gradwohl I, Grubhofer G, Semsroth M. Intubation without muscle relaxation - alfentanil/propofol as an alternative induction regime for children. Anaesthesiology, 89 (3A), abstract A1316 1998.
    Active substance: ALFENTANIL
    Study summary document link (including results): erlacher_alfentanil.pdf
    View full study record
    Document reference: 46360
    Study title: LMD136420 - Robinson DN, O'Brien K, Kumar R, Morton NS. Tracheal intubation without neuromuscular blockade in children: a comparison of propofol combined either with alfentanil or remifentanil. Paediatric Anesthesia, 8, p. 467-471, 1998.LMD136420 - Robinson DN, O'Brien K, Kumar R, Morton NS. Tracheal intubation without neuromuscular blockade in children: a comparison of propofol combined either with alfentanil or remifentanil. Paediatric Anesthesia, 8, p. 467-471, 1998.
    Active substance: ALFENTANIL
    Study summary document link (including results): robinson_alfentanil.pdf
    View full study record
    Document reference: 46359
    Study title: Ng KP and Wang CY Alfentanil for intubation under halothane anaesthesia in children. Paediatric Anaesthesia 9: 491-494, 1999" Ng KP and Wang CY Alfentanil for intubation under halothane anaesthesia in children. Paediatric Anaesthesia 9: 491-494, 1999"
    Active substance: ALFENTANIL
    Study summary document link (including results): ng_alfentanil.pdf
    View full study record
    Document reference: 46371
    Study title: Tracheal intubation without neuromuscular blockade in children: a comprasion of propofol combined either with alfentanil or remifentanil. Paediatric Anaesthesia 8: 467-471, 1998Tracheal intubation without neuromuscular blockade in children: a comprasion of propofol combined either with alfentanil or remifentanil. Paediatric Anaesthesia 8: 467-471, 1998
    Active substance: ALFENTANIL
    Study summary document link (including results): robinson_alfentanil.pdf
    View full study record
    Document reference: 46368
    Study title: Atkinson M, Lakhanpaul M, Smyth A, Vyas H, Weston V, Sithole J, Owen V, Halliday K, Sammons H, Crane J, Guntupalli N, Walton L, Ninan T, Morjaria A, Stephenson T. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax. 2007 Dec;62(12):1102-6. Epub 2007 Jun 13.
    Active substance: AMOXICILLIN
    Study summary document link (including results):
    View full study record
    Document reference: 46596
    Study title: Lockhart PB, Brennan MT, Kent ML, Norton HJ, Weinrib DA. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures. Circulation. 2004 Jun 15;109(23):2878-84. Epub 2004 Jun 1.
    Active substance: AMOXICILLIN
    Study summary document link (including results):
    View full study record
    Document reference: 46605
    Study title: Clinical spectrum and surgical approach of adult intussusceptions: a multicentric study. Barussaud M. And al; International Journal of Colorectal Disease. 21(8):834-9, 2006 Dec.Clinical spectrum and surgical approach of adult intussusceptions: a multicentric study. Barussaud M. And al; International Journal of Colorectal Disease. 21(8):834-9, 2006 Dec.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22157
    Study title: [Congenital gastrointestinal tract obstructions (pictorial essay)]. [Review] [17 refs] [Turkish] Cokun A. Sevinc H.; Tanisal ve Giri Simsel Radyoloji: Tibbi Goruntuleme ve Giri Simsel Radyoloji Dernegi Yayin Organi. 10(1):78-86, 2004 Mar.[Congenital gastrointestinal tract obstructions (pictorial essay)]. [Review] [17 refs] [Turkish] Cokun A. Sevinc H.; Tanisal ve Giri Simsel Radyoloji: Tibbi Goruntuleme ve Giri Simsel Radyoloji Dernegi Yayin Organi. 10(1):78-86, 2004 Mar.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22139
    Study title: The diagnosis of intussusception. Klein EJ. Kapoor D. Shugerman RP.; Clinical Pediatrics. 43(4):343-7, 2004 May. The diagnosis of intussusception. Klein EJ. Kapoor D. Shugerman RP.; Clinical Pediatrics. 43(4):343-7, 2004 May.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22138
    Study title: [Hydrostatic reduction of intestinal intussusception in children. Experience in 43 cases]. [Spanish] Garcia C. And al; Revista Medica de Chile. 125(1):54-61, 1997 Jan. [Hydrostatic reduction of intestinal intussusception in children. Experience in 43 cases]. [Spanish] Garcia C. And al; Revista Medica de Chile. 125(1):54-61, 1997 Jan.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22130
    Study title: Hydrostatic reduction of intussusception: barium, air, or saline?.Shehata S. and al; Pediatric Surgery International. 16(5-6):380-2, 2000.Hydrostatic reduction of intussusception: barium, air, or saline?.Shehata S. and al; Pediatric Surgery International. 16(5-6):380-2, 2000.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22184
    Study title: [Medical-surgical experience of intestinal intussusception. Experience of a university institution]. [Spanish] Montes P. And al; Revista Medica de Chile. 128(3):309-14, 2000 Mar. [Medical-surgical experience of intestinal intussusception. Experience of a university institution]. [Spanish] Montes P. And al; Revista Medica de Chile. 128(3):309-14, 2000 Mar.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22131
    Study title: Relazione clinica sul Tantum verde spray
    Active substance: BENZYDAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 41899
    Study title: Relazione clinica sul Tantum Verde spray
    Active substance: BENZYDAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 41900
    Study title: Relazione sulla sperimentazione del "Tantum Verde pastiglie" in otorinolaringoiatria
    Active substance: BENZYDAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 41885
    Study title: Sperimentazione clinica con il Tantum pasta odontoiatrica in odontostomatologia
    Active substance: BENZYDAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 41896
    1  2  3  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Jun 18 02:58:18 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA